IRADIMED CORP — Director's Dealing 2020

Apr 15, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IRADIMED CORP (IRMD)
CIK: 0001325618
Period of Report: 2020-04-09

Reporting Person: JOHNSON BRENT (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-04-09	Common Stock	M	4000	$1.48	Acquired	6940	Direct
2020-04-09	Common Stock	S	4000	$20.11	Disposed	2940	Direct
2020-04-10	Common Stock	M	2065	—	Acquired	5005	Direct
2020-04-10	Common Stock	F	1342	$19.99	Disposed	3663	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-04-09	Stock Option (Right to Buy)	$1.48	M	4000	Disposed	2023-12-31	Common Stock (4000)	Direct
2020-04-10	Restricted Stock Units	$	M	2065	Disposed		Common Stock (2065)	Direct

Footnotes

F1: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2019.

F2: This transaction was executed in multiple trades at prices ranging from $20.00 to $20.57. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F3: Restricted stock units convert into common stock on a one-for-one basis.

F4: On December 14, 2016, December 4, 2017, and December 7, 2018 the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 14, 2017, December 4, 2018 and December 7, 2019 respectively. The scheduled vestings were accelerated by the registrant, and the restricted stock units became vested as of April 10, 2020. Upon vesting, the reporting person received a number of shares of common stock equal to the number of restricted stock units that vested.

F5: This option, representing a right to purchase a total of 199,759 shares, was granted on December 31, 2013 and vests over 4 years in equal annual installments commencing on the first anniversary of the grant date. 49,939 shares from this award were previously exercised in December 2015.